Mitochondrial Paths to Sarcopenia – A Refined Short Review
Description
Abstract: The current revision aims to report on the geriatric syndrome, well known as sarcopenia, specifically the communication between sarcopenia and mitochondrial pathways. It is predicted that pervasiveness of sarcopenia in community-dwelling elderly people is around 25%, and there is a 5% loss of muscle mass per decade of life from the fourth decade onwards, possibly progressing after the age of 65 years. Muscular mass usually supplies up to ∼50% of total body weight in grown-ups but drops to 25% with aging at 75-80 years old. In the past, several molecular mediators contributing to sarcopenic muscle loss involves ubiquitin proteasomes, inflammatory molecules, and autophagy. Currently, the central roles of mitochondria in the management of sarcopenia are underpinned. However, the collection of scientific evidence suggests that mitochondria have built both direct and indirect physiological implications in controlling muscle physiology and muscle mass in both healthy and diseased conditions, specifically in sarcopenia, the role of mitochondrial pathways epitomize an assuring area of exploration. It is advisable to have an overview of latest discoveries highlighting the mitochondrial function in sarcopenia to generate innovative remedies that can aid to enhance, manage or slow down age-related muscle loss. In the current review, we discuss relevant scientific studies delineating mitochondrial roles and pharmacological therapeutics of sarcopenia.
Files
mitochondrial-paths-to-sarcopenia-a-refined-short-review.pdf
Additional details
References
- Dodson, S., et al., Muscle wasting in cancer cachexia: clinical implications, diagnosis, and emerging treatment strategies. Annu Rev Med, 2011. 62: p. 265-79.
- Kapsa, R., et al., A novel mtDNA deletion in an infant with Pearson syndrome. J Inherit Metab Dis, 1994. 17(5): p. 521-6.
- Lauretani, F., et al., Age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia. J Appl Physiol (1985), 2003. 95(5): p. 1851-60.
- Rizzoli, R., et al., Quality of life in sarcopenia and frailty. Calcif Tissue Int, 2013. 93(2): p. 101-20.
- Vellas, B.J., et al., A two-year longitudinal study of falls in 482 community-dwelling elderly adults. J Gerontol A Biol Sci Med Sci, 1998. 53(4): p. M264-74.
- Walston, J.D., Sarcopenia in older adults. Curr Opin Rheumatol, 2012. 24(6): p. 623-7.
- Kim, T.N. and K.M. Choi, Sarcopenia: definition, epidemiology, and pathophysiology. J Bone Metab, 2013. 20(1): p. 1-10.
- Tzankoff, S.P. and A.H. Norris, Effect of muscle mass decrease on age-related BMR changes. J Appl Physiol Respir Environ Exerc Physiol, 1977. 43(6): p. 1001-6
- Forbes, G.B. and J.C. Reina, Adult lean body mass declines with age: some longitudinal observations. Metabolism, 1970. 19(9): p. 653-63.
- Marcell, T.J., Sarcopenia: causes, consequences, and preventions. J Gerontol A Biol Sci Med Sci, 2003. 58(10): p. M911-6.
- Grimby, G. and B. Saltin, The ageing muscle. Clin Physiol, 1983. 3(3): p. 209-18.
- Hughes, V.A., et al., Longitudinal muscle strength changes in older adults: influence of muscle mass, physical activity, and health. J Gerontol A Biol Sci Med Sci, 2001. 56(5): p. B209-17.
- Goodpaster, B.H., et al., The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. J Gerontol A Biol Sci Med Sci, 2006. 61(10): p. 1059-64
- Short, K.R. and K.S. Nair, The effect of age on protein metabolism. Curr Opin Clin Nutr Metab Care, 2000. 3(1): p. 39- 44.
- Short, K.R., et al., Age and aerobic exercise training effects on whole body and muscle protein metabolism. Am J Physiol Endocrinol Metab, 2004. 286(1): p. E92-101.
- Evans, W.J., Skeletal muscle loss: cachexia, sarcopenia, and inactivity. Am J Clin Nutr, 2010. 91(4): p. 1123S-1127S.
- Camporez, J.P., et al., Anti-myostatin antibody increases muscle mass and strength and improves insulin sensitivity in old mice. Proc Natl Acad Sci U S A, 2016. 113(8): p. 2212-7.
- Calvani, R., et al., Mitochondrial pathways in sarcopenia of aging and disuse muscle atrophy. Biol Chem, 2013. 394(3): p. 393-414.
- Trifunovic, A., et al., Premature ageing in mice expressing defective mitochondrial DNA polymerase. Nature, 2004. 429(6990): p. 417-23.
- Kujoth, G.C., C. Leeuwenburgh, and T.A. Prolla, Mitochondrial DNA mutations and apoptosis in mammalian aging. Cancer Res, 2006. 66(15): p. 7386-9.
- Kujoth, G.C., et al., Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science, 2005. 309(5733): p. 481-4.
- Vermulst, M., et al., DNA deletions and clonal mutations drive premature aging in mitochondrial mutator mice. Nat Genet, 2008. 40(4): p. 392-4.
- Vermulst, M., et al., Mitochondrial point mutations do not limit the natural lifespan of mice. Nat Genet, 2007. 39(4): p. 540-3.
- Hiona, A., et al., Mitochondrial DNA mutations induce mitochondrial dysfunction, apoptosis and sarcopenia in skeletal muscle of mitochondrial DNA mutator mice. PLoS One, 2010. 5(7): p. e11468.
- Joseph, A.M., et al., Dysregulation of mitochondrial quality control processes contribute to sarcopenia in a mouse model of premature aging. PLoS One, 2013. 8(7): p. e69327.
- Joseph, A.M., et al., The impact of aging on mitochondrial function and biogenesis pathways in skeletal muscle of sedentary high- and low-functioning elderly individuals. Aging Cell, 2012. 11(5): p. 801-9.
- . Hutter, E., et al., Oxidative stress and mitochondrial impairment can be separated from lipofuscin accumulation in aged human skeletal muscle. Aging Cell, 2007. 6(2): p. 245-56.
- Lopez-Otin, C., et al., The hallmarks of aging. Cell, 2013. 153(6): p. 1194-217.
- Lewis, K.N., et al., The naked mole-rat response to oxidative stress: just deal with it. Antioxid Redox Signal, 2013. 19(12): p. 1388-99.
- Anderson, R.M. and R. Weindruch, Metabolic reprogramming, caloric restriction and aging. Trends Endocrinol Metab, 2010. 21(3): p. 134-41.
- Twig, G., B. Hyde, and O.S. Shirihai, Mitochondrial fusion, fission and autophagy as a quality control axis: the bioenergetic view. Biochim Biophys Acta, 2008. 1777(9): p. 1092-7.
- Masiero, E., et al., Autophagy is required to maintain muscle mass. Cell Metab, 2009. 10(6): p. 507-15.
- Wanagat, J., et al., Mitochondrial DNA deletion mutations colocalize with segmental electron transport system abnormalities, muscle fiber atrophy, fiber splitting, and oxidative damage in sarcopenia. FASEB J, 2001. 15(2): p. 322-32.
- . Lee, C.M., et al., Multiple mitochondrial DNA deletions associated with age in skeletal muscle of rhesus monkeys. J Gerontol, 1993. 48(6): p. B201-5.
- Bua, E., et al., Mitochondrial DNA-deletion mutations accumulate intracellularly to detrimental levels in aged human skeletal muscle fibers. Am J Hum Genet, 2006. 79(3): p. 469-80.
- Herbst, A., et al., Accumulation of mitochondrial DNA deletion mutations in aged muscle fibers: evidence for a causal role in muscle fiber loss. J Gerontol A Biol Sci Med Sci, 2007. 62(3): p. 235-45.
- Aiken, J., et al., Mitochondrial DNA deletion mutations and sarcopenia. Ann N Y Acad Sci, 2002. 959: p. 412-23.
- Palikaras, K. and N. Tavernarakis, Mitochondrial homeostasis: the interplay between mitophagy and mitochondrial biogenesis. Exp Gerontol, 2014. 56: p. 182-8.
- Aversa, Z., et al., Autophagy is induced in the skeletal muscle of cachectic cancer patients. Scientific Reports, 2016. 6: p. 30340.
- Marzetti, E., et al., Association between myocyte quality control signaling and sarcopenia in old hip-fractured patients: Results from the Sarcopenia in HIp FracTure (SHIFT) exploratory study. Exp Gerontol, 2016. 80: p. 1-5.
- Marzetti, E., et al., Altered mitochondrial quality control signaling in muscle of old gastric cancer patients with cachexia. Exp Gerontol, 2017. 87(Pt A): p. 92-99.
- Jornayvaz, F.R. and G.I. Shulman, Regulation of mitochondrial biogenesis. Essays Biochem, 2010. 47: p. 69-84.
- Virbasius, J.V. and R.C. Scarpulla, Activation of the human mitochondrial transcription factor A gene by nuclear respiratory factors: a potential regulatory link between nuclear and mitochondrial gene expression in organelle biogenesis. Proc Natl Acad Sci U S A, 1994. 91(4): p. 1309-13.
- Conley, K.E., S.A. Jubrias, and P.C. Esselman, Oxidative capacity and ageing in human muscle. J Physiol, 2000. 526 Pt 1: p. 203-10.
- Short, K.R., et al., Decline in skeletal muscle mitochondrial function with aging in humans. Proc Natl Acad Sci U S A, 2005. 102(15): p. 5618-23.
- Safdar, A., et al., Aberrant mitochondrial homeostasis in the skeletal muscle of sedentary older adults. PLoS One, 2010. 5(5): p. e10778.
- Safdar, A., et al., Endurance exercise rescues progeroid aging and induces systemic mitochondrial rejuvenation in mtDNA mutator mice. Proc Natl Acad Sci U S A, 2011. 108(10): p. 4135-40.
- Wright, D.C., et al., Exercise-induced mitochondrial biogenesis begins before the increase in muscle PGC-1alpha expression. J Biol Chem, 2007. 282(1): p. 194-9.
- Sandri, M., et al., PGC-1alpha protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription. Proc Natl Acad Sci U S A, 2006. 103(44): p. 16260-5.
- Cannavino, J., et al., The role of alterations in mitochondrial dynamics and PGC-1alpha over-expression in fast muscle atrophy following hindlimb unloading. J Physiol, 2015. 593(8): p. 1981-95.
- Chabi, B., et al., Mitochondrial function and apoptotic susceptibility in aging skeletal muscle. Aging Cell, 2008. 7(1): p. 2-12.
- . Brault, J.J., J.G. Jespersen, and A.L. Goldberg, Peroxisome proliferator-activated receptor gamma coactivator 1alpha or 1beta overexpression inhibits muscle protein degradation, induction of ubiquitin ligases, and disuse atrophy. J Biol Chem, 2010. 285(25): p. 19460-71.
- Zechner, C., et al., Total skeletal muscle PGC-1 deficiency uncouples mitochondrial derangements from fiber type determination and insulin sensitivity. Cell Metab, 2010. 12(6): p. 633-42.
- Ruas, J.L., et al., A PGC-1alpha isoform induced by resistance training regulates skeletal muscle hypertrophy. Cell, 2012. 151(6): p. 1319-31.
- . Lundberg, T.R., et al., Truncated splice variant PGC-1alpha4 is not associated with exercise-induced human muscle hypertrophy. Acta Physiol (Oxf), 2014. 212(2): p. 142-51.
- . Ydfors, M., et al., The truncated splice variants, NT-PGC-1alpha and PGC-1alpha4, increase with both endurance and resistance exercise in human skeletal muscle. Physiol Rep, 2013. 1(6): p. e00140.
- Hardie, D.G., AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy. Nat Rev Mol Cell Biol, 2007. 8(10): p. 774-85.
- Bergeron, R., et al., Chronic activation of AMP kinase results in NRF-1 activation and mitochondrial biogenesis. Am J Physiol Endocrinol Metab, 2001. 281(6): p. E1340-6.
- Reznick, R.M., et al., Aging-associated reductions in AMPactivated protein kinase activity and mitochondrial biogenesis. Cell Metab, 2007. 5(2): p. 151-6.
- Lanza, I.R., et al., Endurance exercise as a countermeasure for aging. Diabetes, 2008. 57(11): p. 2933-42.
- Lagouge, M., et al., Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell, 2006. 127(6): p. 1109-22.
- Gomes, A.P., et al., Declining NAD(+) induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging. Cell, 2013. 155(7): p. 1624-38.
- Pirinen, E., et al., Pharmacological Inhibition of poly(ADPribose) polymerases improves fitness and mitochondrial function in skeletal muscle. Cell Metab, 2014. 19(6): p. 1034-41.
- Harris, T.B., et al., Association of insulin-like growth factor-I with body composition, weight history, and past health behaviors in the very old: the Framingham Heart Study. J Am Geriatr Soc, 1997. 45(2): p. 133-9.
- Das, S., et al., ATP citrate lyase improves mitochondrial function in skeletal muscle. Cell Metab, 2015. 21(6): p. 868-76.
- Romanello, V. and M. Sandri, Mitochondrial Quality Control and Muscle Mass Maintenance. Front Physiol, 2015. 6: p. 422
- Kennedy, B.K., et al., Geroscience: linking aging to chronic disease. Cell, 2014. 159(4): p. 709-13.
- Baker, B.M. and C.M. Haynes, Mitochondrial protein quality control during biogenesis and aging. Trends Biochem Sci, 2011. 36(5): p. 254-61.
- Quiros, P.M., T. Langer, and C. Lopez-Otin, New roles for mitochondrial proteases in health, ageing and disease. Nat Rev Mol Cell Biol, 2015. 16(6): p. 345-59.
- Voos, W., Chaperone-protease networks in mitochondrial protein homeostasis. Biochim Biophys Acta, 2013. 1833(2): p. 388-99.
- Ngo, J.K., L.C. Pomatto, and K.J. Davies, Upregulation of the mitochondrial Lon Protease allows adaptation to acute oxidative stress but dysregulation is associated with chronic stress, disease, and aging. Redox Biol, 2013. 1: p. 258-64.
- Kang, S., et al., Loss of HtrA2/Omi activity in non-neuronal tissues of adult mice causes premature aging. Cell Death Differ, 2013. 20(2): p. 259-69.
- Gispert, S., et al., Loss of mitochondrial peptidase Clpp leads to infertility, hearing loss plus growth retardation via accumulation of CLPX, mtDNA and inflammatory factors. Hum Mol Genet, 2013. 22(24): p. 4871-87.
- Maltecca, F., et al., The mitochondrial protease AFG3L2 is essential for axonal development. J Neurosci, 2008. 28(11): p. 2827-36.
- Cipolat, S., et al., Mitochondrial rhomboid PARL regulates cytochrome c release during apoptosis via OPA1-dependent cristae remodeling. Cell, 2006. 126(1): p. 163-75.
- Lopez, L.M., et al., Evolutionary conserved longevity genes and human cognitive abilities in elderly cohorts. Eur J Hum Genet, 2012. 20(3): p. 341-7.
- Mizushima, N., Autophagy: process and function. Genes Dev, 2007. 21(22): p. 2861-73.
- Nakatogawa, H., et al., Dynamics and diversity in autophagy mechanisms: lessons from yeast. Nat Rev Mol Cell Biol, 2009. 10(7): p. 458-67.
- Yang, Z. and D.J. Klionsky, Mammalian autophagy: core molecular machinery and signaling regulation. Curr Opin Cell Biol, 2010. 22(2): p. 124-31.
- Rodriguez-Enriquez, S., et al., Tracker dyes to probe mitochondrial autophagy (mitophagy) in rat hepatocytes. Autophagy, 2006. 2(1): p. 39-46.
- Del Roso, A., et al., Ageing-related changes in the in vivo function of rat liver macroautophagy and proteolysis. Exp Gerontol, 2003. 38(5): p. 519-27.
- Wu, J.J., et al., Increased mammalian lifespan and a segmental and tissue-specific slowing of aging after genetic reduction of mTOR expression. Cell Rep, 2013. 4(5): p. 913-20.
- LaRocca, T.J., et al., Mitochondrial quality control and ageassociated arterial stiffening. Exp Gerontol, 2014. 58: p. 78-82.
- White, Z., et al., High mTORC1 signaling is maintained, while protein degradation pathways are perturbed in old murine skeletal muscles in the fasted state. Int J Biochem Cell Biol, 2016. 78: p. 10-21.
- Russ, D.W., et al., "SR stress" in mixed hindlimb muscles of aging male rats. Biogerontology, 2012. 13(5): p. 547-55.
- Sebastian, D., et al., Mfn2 deficiency links age-related sarcopenia and impaired autophagy to activation of an adaptive mitophagy pathway. EMBO J, 2016. 35(15): p. 1677-93.
- . Clark, I.E., et al., Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin. Nature, 2006. 441(7097): p. 1162-6.
- Bujak, A.L., et al., AMPK activation of muscle autophagy prevents fasting-induced hypoglycemia and myopathy during aging. Cell Metab, 2015. 21(6): p. 883-90.
- Castets, P., et al., Sustained activation of mTORC1 in skeletal muscle inhibits constitutive and starvation-induced autophagy and causes a severe, late-onset myopathy. Cell Metab, 2013. 17(5): p. 731-44
- Cui, J., et al., Mitochondrial autophagy involving renal injury and aging is modulated by caloric intake in aged rat kidneys. PLoS One, 2013. 8(7): p. e69720.
- Garcia-Prat, L., et al., Autophagy maintains stemness by preventing senescence. Nature, 2016. 529(7584): p. 37-42.
- Crane, J.D., et al., The effect of aging on human skeletal muscle mitochondrial and intramyocellular lipid ultrastructure. J Gerontol A Biol Sci Med Sci, 2010. 65(2): p. 119-28.
- Lee, S., et al., Mitochondrial fission and fusion mediators, hFis1 and OPA1, modulate cellular senescence. J Biol Chem, 2007. 282(31): p. 22977-83.
- Yoon, Y.S., et al., Formation of elongated giant mitochondria in DFO‐induced cellular senescence: Involvement of enhanced fusion process through modulation of Fis1. Journal of Cellular Physiology, 2006. 209(2): p. 468-480.
- Onder, G., et al., Relation between use of angiotensin-converting enzyme inhibitors and muscle strength and physical function in older women: an observational study. Lancet, 2002. 359(9310): p. 926-30.
- Sumukadas, D., et al., Ace inhibitors as a therapy for sarcopenia - evidence and possible mechanisms. J Nutr Health Aging, 2008. 12(7): p. 480-5.
- Witham, M.D., D. Sumukadas, and M.E. McMurdo, ACE inhibitors for sarcopenia--as good as exercise training? Age Ageing, 2008. 37(4): p. 363-5.
- . Burks, T.N., et al., Losartan restores skeletal muscle remodeling and protects against disuse atrophy in sarcopenia. Sci Transl Med, 2011. 3(82): p. 82ra37.
- Wang, X., et al., Insulin resistance accelerates muscle protein degradation: Activation of the ubiquitin-proteasome pathway by defects in muscle cell signaling. Endocrinology, 2006. 147(9): p. 4160-8.
- Asp, M.L., et al., Evidence for the contribution of insulin resistance to the development of cachexia in tumor-bearing mice. Int J Cancer, 2010. 126(3): p. 756-63.
- Derbre, F., et al., Inhibition of xanthine oxidase by allopurinol prevents skeletal muscle atrophy: role of p38 MAPKinase and E3 ubiquitin ligases. PLoS One, 2012. 7(10): p. e46668.
- Beveridge, L.A., et al., Allopurinol use is associated with greater functional gains in older rehabilitation patients. Age Ageing, 2013. 42(3): p. 400-4.
- Fujii, C., et al., Treatment of sarcopenia and glucose intolerance through mitochondrial activation by 5-aminolevulinic acid. Scientific Reports, 2017. 7(1): p. 4013.
- Jones, T.E., et al., Sarcopenia - Mechanisms and Treatments. Journal of Geriatric Physical Therapy, 2009. 32(2): p. 39-45.
- Yue, W., et al., A small natural molecule promotes mitochondrial fusion through inhibition of the deubiquitinase USP30. Cell Res, 2014. 24(4): p. 482-96.
- Bertelsen, B., et al., Intragenic deletions affecting two alternative transcripts of the IMMP2L gene in patients with Tourette syndrome. Eur J Hum Genet, 2014. 22(11): p. 1283-9.
- Almontashiri, N.A., et al., SPG7 variant escapes phosphorylation-regulated processing by AFG3L2, elevates mitochondrial ROS, and is associated with multiple clinical phenotypes. Cell Rep, 2014. 7(3): p. 834-47.
- Jenkinson, E.M., et al., Perrault syndrome is caused by recessive mutations in CLPP, encoding a mitochondrial ATP-dependent chambered protease. Am J Hum Genet, 2013. 92(4): p. 605-13.
- . Kondadi, A.K., et al., Loss of the m-AAA protease subunit AFG(3)L(2) causes mitochondrial transport defects and tau hyperphosphorylation. EMBO J, 2014. 33(9): p. 1011-26.
- Reddy, P.H., Inhibitors of mitochondrial fission as a therapeutic strategy for diseases with oxidative stress and mitochondrial dysfunction. J Alzheimers Dis, 2014. 40(2): p. 245-56.
- Cassidy-Stone, A., et al., Chemical inhibition of the mitochondrial division dynamin reveals its role in Bax/Bakdependent mitochondrial outer membrane permeabilization. Dev Cell, 2008. 14(2): p. 193-204.
- Qi, X., et al., A novel Drp1 inhibitor diminishes aberrant mitochondrial fission and neurotoxicity. J Cell Sci, 2013. 126(Pt 3): p. 789-802.
- Macia, E., et al., Dynasore, a cell-permeable inhibitor of dynamin. Dev Cell, 2006. 10(6): p. 839-50.